We must all get vaccinated and self isolate ourselves, avoid crowded and confined spaces. Please take all the precautionary measures to prevent from getting infected. More importantly when we gather again in time, from the head count no one is missing. Stay safe and stay home pic.twitter.com/sAPbwfi4ip
There's a million reasons to get vaccinated - but for me, it's Mum. She still lives out in Wang, not far from where I grew up. I love her, and I think about her every day. Even if this pandemic means I can't see her as much as I'd like, I still want to know that she's safe. pic.twitter.com/euOFuw9xlN
📍Over **1 MILLION VACCINE DOSES** have been wasted in US. Booster shots are critical right now with the #DeltaVariant plus also waning efficacy after 6 months. Don’t waste! Use it to save lives or ship it overseas! Me & @AliHMokdad of @IHME_UW #COVID19🧵 www.thinkglobalhealth.org/article/time-smart-approach-boosters pic.twitter.com/bsUR1IpVje
Good Evening, & welcome to the sixth of 8 live winner announcement events for #VaxNevadaDays — a celebration of #COVID19 vaccines & all the benefits they bring. Follow along on @NVHealthRespon1 live YouTube feed here: www.youtube.com/channel/UCcdWZS9igTKYEmb9TjPruAw pic.twitter.com/QIjCT1L8dw
The update to the original emergency use authorizations that allowed Covid vaccines to be used could come as soon as Thursday, according to NBC News, which cited two people familiar with the plan. Last month, a panel of advisors to the Centers for Disease Control and Prevention urged booster shots for immunocompromised adults.
All three vaccine stocks have boomeranged this week. BioNTech, Moderna and Pfizer stocks roared to record highs on Tuesday, only to take a collective tumble on Wednesday. But the possibility of FDA-authorized booster shots sent them higher again on Thursday.
No Covid vaccine is 100% effective against infection. And people with compromised immune systems are more susceptible even after being inoculated. That's because their immune systems might not have effectively responded to the shots.
It's unclear which people would be eligible for a third booster shot. The CDC estimates roughly 2.7% of U.S. adults are immunocompromised. This group includes cancer patients, organ transplant recipients, people living with HIV and others.
Immunocompromised people are more likely to have a severe and prolonged case of Covid, transmit the virus to other people in their house and experience a breakthrough infection following vaccination. Of people in U.S. hospitals with breakthrough cases, 44% are immunocompromised.
Adding a third booster shot could help already strong sales for the three vaccine stocks.
In the second quarter, Pfizer guided to $33.5 billion in full-year sales of its BioNTech-partnered Covid shot. That's based on signed contracts for 2.1 billion doses to be delivered this year. Both numbers are likely to increase as Pfizer and BioNTech ink new deals.
Moderna said it had signed deals for $20 billion worth of Covid vaccine doses in 2021. This year, the company says it can manufacture 800 million to 1 billion doses. For 2022, Moderna already has signed deals for $12 billion worth of product and options for 8 $billion more.
5:11 AM ET Is AbbVie stock a buy or a sell as it works on a next-generation version of Biogen's Alzheimer's disease treatment,...
5:11 AM ET Is AbbVie stock a buy or a sell as it...
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2021 Investor's Business Daily, LLC. All rights reserved
Read full article at Investor's Business Daily